Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome

Clinical Autonomic Research

Volumn 6, Issue 1, 1996, Pages 17-21

  Goldstein, D S ^a   McRae, A ^b   Holmes, C ^a   Dalakas, M C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dihydroxyphenylglycol; Dysautonomia; Norepinephrine; Shy drager syndrome; Sympathetic nervous system

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NORADRENALIN; PARAPROTEIN;

ADRENERGIC SYSTEM; ADULT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; AUTONOMIC DYSFUNCTION; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; FUNCTION TEST; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; LOWER BODY NEGATIVE PRESSURE; MALE; MULTIPLE MYELOMA; NERVE FUNCTION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PROTEIN BINDING; RAT; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA;

ANIMALS; AUTOIMMUNE DISEASES; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RATS; RATS, SPRAGUE-DAWLEY; SHY-DRAGER SYNDROME;

EID: 0029965743     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02291401     Document Type: Article

References (17)

1. Goldstein DS, Polinsky RJ, Garty M et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 1989; 26: 558-563.
2. Ziegler MG, Lake CR, Kopin IJ. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 1977; 296: 293-297.
3. Murphy W, Mann R, McGrath BP, Bell C. Neuronal antibodies and autonomic failure [letter]. Lancet 1993; 342: 563.
4. Polinsky RJ, McRae A, Baser SM, Dahlstrom A. Antibody in the CSF of patients with multiple system atrophy reacts specifically with rat locus ceruleus. J Neural Sci 1991; 106: 96-104.
5. Angeletti PU, Levi-Montalcini R. Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopamine-mice and rats-immunosympathectomy-chemical sympathectomy-superior cervical ganglion). Proc Natl Acad Sci USA 1972; 69: 86-88.
6. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 1991; 260: R142-R147.
7. Goldstein DS, Eisenhofer G, Garty M, Sax FL, Keiser HR, Kopin IJ. Pharmacologic and tracer methods to study sympathetic function in primary hypertension. Clin Exp Hypertens 1989; A11 (Suppl. I): 173-189.
8. Grossman E, Chang PC, Hoffman A, Tamrat M, Kopin IJ, Goldstein DS. Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion. Am J Physiol 1991; 260: R946-R952.
9. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 1991; 260: R142-R147.
10. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1994; 653: 131-138.
11. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest 1988; 81: 213-220.
12. Dalakas MC, Illa I, Dambrosia JM et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermalomyositis. N Engl J Med 1993; 329: 1993-2000.
13. Goldstein DS, Grossman E, Listwak S, Folio CJ. Sympathetic reactivity during a yohimbine challenge test in essential hypertension. Hypertension 1991; 18 (Suppl. III): III-40-III-48.
14. Shu SY, Ju G, Fan LZ. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988; 85: 169-171.
15. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension 1992; 19: 628-633.
16. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 1994; 34: 418-423.
17. Robertson D, Goldberg MR, Tung CS, Hollister AS, Robertson RM. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Invest 1986; 78: 576-581.